Back to Search
Start Over
Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: IS ICC -applied prediction model.
- Source :
-
Cancer science [Cancer Sci] 2020 Apr; Vol. 111 (4), pp. 1084-1092. Date of Electronic Publication: 2020 Feb 12. - Publication Year :
- 2020
-
Abstract
- Intrahepatic cholangiocarcinoma (ICC) remains a highly heterogeneous disease with poor prognosis. Tumor-infiltrating lymphocytes were predictive in various cancers, but their prognostic value in ICC is less clear. A total of 168 ICC patients who had received liver resection were enrolled and assigned to the derivation cohort. Sixteen immune markers in tumor and peritumor regions were examined by immunohistochemistry. A least absolute shrinkage and selection operator model was used to identify prognostic markers and to establish an immune signature for ICC (IS <subscript>ICC</subscript> ). An IS <subscript>ICC</subscript> -applied prediction model was built and validated in another independent dataset. Five immune features, including CD3 <subscript>peritumor (P)</subscript> , CD57 <subscript>P</subscript> , CD45RA <subscript>P</subscript> , CD66b <subscript>intratumoral (T)</subscript> and PD-L1 <subscript>P</subscript> , were identified and integrated into an individualized IS <subscript>ICC</subscript> for each patient. Seven prognostic predictors, including total bilirubin, tumor numbers, CEA, CA19-9, GGT, HBsAg and IS <subscript>ICC</subscript> , were integrated into the final model. The C-index of the IS <subscript>ICC</subscript> -applied prediction model was 0.719 (95% CI, 0.660-0.777) in the derivation cohort and 0.667 (95% CI, 0.581-0.732) in the validation cohort. Compared with the conventional staging systems, the new model presented better homogeneity and a lower Akaike information criteria value in ICC. The IS <subscript>ICC</subscript> -applied prediction model may provide a better prediction performance for the overall survival of patients with resectable ICC in clinical practice.<br /> (© 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
- Subjects :
- Aged
Cholangiocarcinoma epidemiology
Cholangiocarcinoma pathology
Cohort Studies
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic genetics
Hepatectomy
Humans
Liver Neoplasms epidemiology
Liver Neoplasms pathology
Male
Middle Aged
Neoplasm Proteins genetics
Cholangiocarcinoma surgery
Liver Neoplasms surgery
Lymphocytes, Tumor-Infiltrating pathology
Prognosis
Subjects
Details
- Language :
- English
- ISSN :
- 1349-7006
- Volume :
- 111
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Cancer science
- Publication Type :
- Academic Journal
- Accession number :
- 31971309
- Full Text :
- https://doi.org/10.1111/cas.14315